FDA STATE_REFERRAL_LETTER - lincare, inc. - March 20, 2017

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

This STATE REFERRAL LETTER record concerns lincare, inc. , with an inspection on March 20, 2017, issued by the Office of Pharmaceutical Quality, covering drugs.

Company: lincare, inc.
Inspection Date: March 20, 2017
Product Type: Drugs
Office: Office of Pharmaceutical Quality
People: Phillip R. Pylant (Mr.)
Thao Ta (Compliance Officer)
John W. Diehl (John W. Diehl, M.S.Program Division)
Chelsey Chandler
Gregory McCarthy

Open in Dashboard

ID · 29b83c18-11ef-42ef-bced-018c20e940ad

Violation Codes3

21 CFR 20.64(d)(3)21 CFR 20.88FD&C Act 503A(a)

Full citation text and observation details available on the Dashboard.